# Alta Equipment Group Inc.: financial statements, quarterly

ALTG · NYSE · CIK 1759824 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/altg.md) · [Financials](/companies/altg/financials.md) · [Filings](/companies/altg/filings.md) · [Insiders](/companies/altg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/altg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [466](/filings/0000950170-24-125441.md) | [522 d](/filings/0001193125-26-076932.md) | [442](/filings/0000950170-25-065698.md) | [488](/filings/0000950170-25-105063.md) | [449](/filings/0001193125-25-269614.md) | [498 d](/filings/0001193125-26-076932.md) | [423](/filings/0001193125-26-212008.md) | [481](/filings/0001193125-26-338075.md) | [423](/filings/0001193125-25-269614.md) | [509 d](/filings/0001193125-26-076932.md) | [411](/filings/0001193125-26-212008.md) | [476](/filings/0001193125-26-338075.md) |
| Cost of revenue | $m | [340](/filings/0000950170-24-125441.md) | [389 d](/filings/0001193125-26-076932.md) | [321](/filings/0000950170-25-065698.md) | [356](/filings/0000950170-25-105063.md) | [324](/filings/0001193125-25-269614.md) | [382 d](/filings/0001193125-26-076932.md) | [308](/filings/0001193125-26-212008.md) | [359](/filings/0001193125-26-338075.md) | [305](/filings/0001193125-25-269614.md) | [390 d](/filings/0001193125-26-076932.md) | [301](/filings/0001193125-26-212008.md) | [351](/filings/0001193125-26-338075.md) |
| Gross profit | $m | [126](/filings/0000950170-24-125441.md) | [133 d](/filings/0001193125-26-076932.md) | [121](/filings/0000950170-25-065698.md) | [132](/filings/0000950170-25-105063.md) | [125](/filings/0001193125-25-269614.md) | [117 d](/filings/0001193125-26-076932.md) | [115](/filings/0001193125-26-212008.md) | [122](/filings/0001193125-26-338075.md) | [118](/filings/0001193125-25-269614.md) | [120 d](/filings/0001193125-26-076932.md) | [109](/filings/0001193125-26-212008.md) | [124](/filings/0001193125-26-338075.md) |
| Selling, general and administrative | $m | not reported | not reported | [115](/filings/0000950170-25-065698.md) | [115](/filings/0000950170-25-105063.md) | [111](/filings/0001193125-25-269614.md) | [107 d](/filings/0001193125-26-076932.md) | [107](/filings/0001193125-26-212008.md) | [102](/filings/0001193125-26-338075.md) | [106](/filings/0001193125-25-269614.md) | [108 d](/filings/0001193125-26-076932.md) | [108](/filings/0001193125-26-212008.md) | [106](/filings/0001193125-26-338075.md) |
| Operating income | $m | [13.9](/filings/0000950170-24-125441.md) | [12.2 d](/filings/0001193125-26-076932.md) | [(0.9)](/filings/0000950170-25-065698.md) | [10.3](/filings/0000950170-25-105063.md) | [6.8](/filings/0001193125-25-269614.md) | [2.4 d](/filings/0001193125-26-076932.md) | [0.8](/filings/0001193125-26-212008.md) | [12.4](/filings/0001193125-26-338075.md) | [4.8](/filings/0001193125-25-269614.md) | [5.2 d](/filings/0001193125-26-076932.md) | [(5.7)](/filings/0001193125-26-212008.md) | [12.0](/filings/0001193125-26-338075.md) |
| Interest expense | $m | [15.2](/filings/0000950170-24-125441.md) | [16.1 d](/filings/0001193125-26-076932.md) | [16.1](/filings/0000950170-25-065698.md) | [19.2](/filings/0000950170-25-105063.md) | [22.6](/filings/0001193125-25-269614.md) | [23.4 d](/filings/0001193125-26-076932.md) | [21.9](/filings/0001193125-26-212008.md) | [22.3](/filings/0001193125-26-338075.md) | [22.4](/filings/0001193125-25-269614.md) | [21.8 d](/filings/0001193125-26-076932.md) | [19.5](/filings/0001193125-26-212008.md) | [19.5](/filings/0001193125-26-338075.md) |
| Income tax | $m | [(7.3)](/filings/0000950170-24-125441.md) | [0.5 d](/filings/0001193125-26-076932.md) | [(4.2)](/filings/0000950170-25-065698.md) | [(2.7)](/filings/0000950170-25-105063.md) | [11.6](/filings/0001193125-25-269614.md) | [(8.9) d](/filings/0001193125-26-076932.md) | [0.7](/filings/0001193125-26-212008.md) | [1.3](/filings/0001193125-26-338075.md) | [24.4](/filings/0001193125-25-269614.md) | [(4.9) d](/filings/0001193125-26-076932.md) | [(3.8)](/filings/0001193125-26-212008.md) | [(0.4)](/filings/0001193125-26-338075.md) |
| Net income | $m | [7.4](/filings/0000950170-24-125441.md) | [(1.9) d](/filings/0001193125-26-076932.md) | [(11.9)](/filings/0000950170-25-065698.md) | [(11.9)](/filings/0000950170-25-105063.md) | [(27.7)](/filings/0001193125-25-269614.md) | [(10.6) d](/filings/0001193125-26-076932.md) | [(20.9)](/filings/0001193125-26-212008.md) | [(6.1)](/filings/0001193125-26-338075.md) | [(41.6)](/filings/0001193125-25-269614.md) | [(11.7) d](/filings/0001193125-26-076932.md) | [(19.5)](/filings/0001193125-26-212008.md) | [(7.5)](/filings/0001193125-26-338075.md) |
| Diluted EPS | $ per share | [0.20](/filings/0000950170-24-125441.md) | not reported | [(0.38)](/filings/0000950170-25-065698.md) | [(0.38)](/filings/0000950170-25-105063.md) | [(0.86)](/filings/0001193125-25-269614.md) | not reported | [(0.65)](/filings/0001193125-26-212008.md) | [(0.21)](/filings/0001193125-26-338075.md) | [(1.31)](/filings/0001193125-25-269614.md) | not reported | [(0.62)](/filings/0001193125-26-212008.md) | [(0.25)](/filings/0001193125-26-338075.md) |
| Basic EPS | $ per share | [0.21](/filings/0000950170-24-125441.md) | not reported | [(0.38)](/filings/0000950170-25-065698.md) | [(0.38)](/filings/0000950170-25-105063.md) | [(0.86)](/filings/0001193125-25-269614.md) | not reported | [(0.65)](/filings/0001193125-26-212008.md) | [(0.21)](/filings/0001193125-26-338075.md) | [(1.31)](/filings/0001193125-25-269614.md) | not reported | [(0.62)](/filings/0001193125-26-212008.md) | [(0.25)](/filings/0001193125-26-338075.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.4](/filings/0000950170-23-061146.md) | [31.0](/filings/0000950170-25-033669.md) | [5.6](/filings/0000950170-24-055802.md) | [4.5](/filings/0000950170-24-092871.md) | [14.6](/filings/0000950170-24-125441.md) | [13.4](/filings/0001193125-26-076932.md) | [11.1](/filings/0000950170-25-065698.md) | [13.2](/filings/0000950170-25-105063.md) | [14.1](/filings/0001193125-25-269614.md) | [18.6](/filings/0001193125-26-338075.md) | [23.9](/filings/0001193125-26-212008.md) | [20.9](/filings/0001193125-26-338075.md) |
| Current assets | $m | [784](/filings/0000950170-23-061146.md) | [838](/filings/0000950170-25-033669.md) | [822](/filings/0000950170-24-055802.md) | [836](/filings/0000950170-24-092871.md) | [826](/filings/0000950170-24-125441.md) | [775](/filings/0001193125-26-076932.md) | [792](/filings/0000950170-25-065698.md) | [739](/filings/0000950170-25-105063.md) | [772](/filings/0001193125-25-269614.md) | [710](/filings/0001193125-26-338075.md) | [724](/filings/0001193125-26-212008.md) | [725](/filings/0001193125-26-338075.md) |
| Total assets | $m | [1,480](/filings/0000950170-23-061146.md) | [1,571](/filings/0001193125-26-076932.md) | [1,563](/filings/0000950170-25-065698.md) | [1,591](/filings/0000950170-25-105063.md) | [1,549](/filings/0001193125-25-269614.md) | [1,480](/filings/0001193125-26-076932.md) | [1,505](/filings/0001193125-26-212008.md) | [1,436](/filings/0001193125-26-338075.md) | [1,431](/filings/0001193125-25-269614.md) | [1,336](/filings/0001193125-26-338075.md) | [1,335](/filings/0001193125-26-212008.md) | [1,323](/filings/0001193125-26-338075.md) |
| Current liabilities | $m | [570](/filings/0000950170-23-061146.md) | [635](/filings/0000950170-25-033669.md) | [631](/filings/0000950170-24-055802.md) | [610](/filings/0000950170-24-092871.md) | [612](/filings/0000950170-24-125441.md) | [577](/filings/0001193125-26-076932.md) | [584](/filings/0000950170-25-065698.md) | [531](/filings/0000950170-25-105063.md) | [543](/filings/0001193125-25-269614.md) | [495](/filings/0001193125-26-338075.md) | [528](/filings/0001193125-26-212008.md) | [524](/filings/0001193125-26-338075.md) |
| Total liabilities | $m | [1,333](/filings/0000950170-23-061146.md) | [1,421](/filings/0000950170-25-033669.md) | [1,426](/filings/0000950170-24-055802.md) | [1,466](/filings/0000950170-24-092871.md) | [1,453](/filings/0000950170-24-125441.md) | [1,403](/filings/0001193125-26-076932.md) | [1,449](/filings/0000950170-25-065698.md) | [1,392](/filings/0000950170-25-105063.md) | [1,428](/filings/0001193125-25-269614.md) | [1,345](/filings/0001193125-26-338075.md) | [1,363](/filings/0001193125-26-212008.md) | [1,359](/filings/0001193125-26-338075.md) |
| Long-term debt | $m | [312](/filings/0000950170-23-061146.md) | [312](/filings/0000950170-25-033669.md) | [313](/filings/0000950170-24-055802.md) | [477](/filings/0000950170-24-092871.md) | [479](/filings/0000950170-24-125441.md) | [480](/filings/0001193125-26-076932.md) | [481](/filings/0000950170-25-065698.md) | [482](/filings/0000950170-25-105063.md) | [483](/filings/0001193125-25-269614.md) | [485](/filings/0001193125-26-338075.md) | [485](/filings/0001193125-26-212008.md) | [486](/filings/0001193125-26-338075.md) |
| Current portion of debt | $m | [6.6](/filings/0000950170-23-061146.md) | [7.7](/filings/0000950170-25-033669.md) | [8.5](/filings/0000950170-24-055802.md) | [9.4](/filings/0000950170-24-092871.md) | [10.1](/filings/0000950170-24-125441.md) | [10.5](/filings/0001193125-26-076932.md) | [11.2](/filings/0000950170-25-065698.md) | [11.3](/filings/0000950170-25-105063.md) | [11.0](/filings/0001193125-25-269614.md) | [11.0](/filings/0001193125-26-338075.md) | [11.1](/filings/0001193125-26-212008.md) | [10.9](/filings/0001193125-26-338075.md) |
| Shareholders' equity | $m | [148](/filings/0000950170-24-125441.md) | [150](/filings/0001193125-26-076932.md) | [137](/filings/0001193125-25-269614.md) | [125](/filings/0001193125-25-269614.md) | [95.7](/filings/0001193125-25-269614.md) | [77.6](/filings/0001193125-26-338075.md) | [56.0](/filings/0001193125-26-338075.md) | [43.9](/filings/0001193125-26-338075.md) | [2.9](/filings/0001193125-25-269614.md) | [(8.8)](/filings/0001193125-26-338075.md) | [(28.3)](/filings/0001193125-26-338075.md) | [(36.2)](/filings/0001193125-26-338075.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.7 d](/filings/0000950170-24-125441.md) | [81.5 d](/filings/0001193125-26-076932.md) | [(13.5)](/filings/0000950170-25-065698.md) | [(10.7) d](/filings/0000950170-25-105063.md) | [46.3 d](/filings/0001193125-25-269614.md) | [34.9 d](/filings/0001193125-26-076932.md) | [(17.5)](/filings/0001193125-26-212008.md) | [14.1 d](/filings/0001193125-26-338075.md) | [2.5 d](/filings/0001193125-25-269614.md) | [33.9 d](/filings/0001193125-26-076932.md) | [20.8](/filings/0001193125-26-212008.md) | [5.3 d](/filings/0001193125-26-338075.md) |
| Capital expenditure | $m | [2.5 d](/filings/0000950170-24-125441.md) | [3.8 d](/filings/0001193125-26-076932.md) | [4.4](/filings/0000950170-25-065698.md) | [2.8 d](/filings/0000950170-25-105063.md) | [4.2 d](/filings/0001193125-25-269614.md) | [4.0 d](/filings/0001193125-26-076932.md) | [1.7](/filings/0001193125-26-212008.md) | [2.2 d](/filings/0001193125-26-338075.md) | [4.2 d](/filings/0001193125-25-269614.md) | [1.1 d](/filings/0001193125-26-076932.md) | [3.0](/filings/0001193125-26-212008.md) | [3.0 d](/filings/0001193125-26-338075.md) |
| Dividends paid | $m | [0.7 d](/filings/0000950170-24-125441.md) | [0.8 d](/filings/0001193125-26-076932.md) | [0.8](/filings/0000950170-25-065698.md) | [0.7 d](/filings/0000950170-25-105063.md) | [0.7 d](/filings/0001193125-25-269614.md) | [0.8 d](/filings/0001193125-26-076932.md) | [0.8](/filings/0001193125-26-212008.md) | [0.7 d](/filings/0001193125-26-338075.md) | [0.7 d](/filings/0001193125-25-269614.md) | [0.8 d](/filings/0001193125-26-076932.md) | [0.8](/filings/0001193125-26-212008.md) | [0.7 d](/filings/0001193125-26-338075.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001193125-25-269614.md) | [3.8 d](/filings/0001193125-26-076932.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-269614.md) | [1.0 d](/filings/0001193125-26-076932.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.1](/filings/0000950170-23-061146.md) | [32.4](/filings/0000950170-24-055802.md) | [32.7](/filings/0000950170-24-092871.md) | [32.7](/filings/0000950170-24-125441.md) | [33.1](/filings/0000950170-25-065698.md) | [33.2](/filings/0000950170-25-105063.md) | [33.2](/filings/0001193125-25-269614.md) | [33.2](/filings/0001193125-26-212008.md) | [33.0](/filings/0001193125-26-338075.md) | [32.3](/filings/0001193125-25-269614.md) | [32.6](/filings/0001193125-26-212008.md) | [32.8](/filings/0001193125-26-338075.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 32,666,872 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-338075.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.